Single-Use Technologies Prove Effective for Viral Vector Process Development: The benefits of single-use technologies for upstream viral-vector processes clearly outweigh their disadvantages.
| Publicado en: | BioPharm International Vol. 34; no. 8; pp. 12 - 18 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Aug2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151827106&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 151827106 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Aug2021 vid: 34 iid: 8 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 151827106 151827106 ppf: 12 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Single-Use Technologies Prove Effective for Viral Vector Process Development: The benefits of single-use technologies for upstream viral-vector processes clearly outweigh their disadvantages. aug: au: CHALLENER, CYNTHIA A. sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|